Source: Outcomes4Me From: prnewswire.com Update includes new treatments, pembrolizumab and olaparib, for early-stage breast cancer today announced it has updated its mobile app to include the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Breast Cancer V.6.2021 released last week. The app serves as a digital health partner that proactively delivers timely information of value to empower patients to …